Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report

Docetaxel (DOC) is one of the most effective agents for breast cancer treatment. Here, we report docetaxel-induced severe hypertriglyceridemia in a patient previously diagnosed with hyperlipidemia and corresponding therapeutic intervention. A postmenopausal woman, with previously controlled hyperlip...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Yoshitaka, Takekuma, Yoh, Takeshita, Takashi, Sugawara, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460953/
https://www.ncbi.nlm.nih.gov/pubmed/34720928
http://dx.doi.org/10.1159/000518684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460953/
https://www.ncbi.nlm.nih.gov/pubmed/34720928
http://dx.doi.org/10.1159/000518684

Ejemplares similares